Post-Covid syndrome is a condition that often occurs in subject who have had mild or severe Sars-CoV-2 infection and it is mainly characterized by chronic fatigue. Recently a published study evaluated a nutritional supplement, supporting immune function and energy metabolism (Apportal®, Pharmanutra), on chronic fatigue after Sars-CoV-2 infection.
PharmaNutra R&D laboratory
Image Credit: PharmaNutra
Results of the study showed a significant improvement in quality of life and chronic fatigue both after 14 and 28 days of taking Apportal®. The condition of chronic fatigue observed in these SARS-CoV-2 infected subjects is comparable with those observed in other chronic diseases. Apportal® can be a quick and easy opportunity to counteract chronic fatigue.